Cited by 215Adrenal and Paraganglionic TumorsMedical Imaging Techniques and ApplicationsNeuroendocrine Tumor Research Advances

The DOI matches its Crossref record; 47 of the 53 references it cites were found in a registry or an index.

18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients

Groussin, Lionel, Bonardel, Gérald, Silvéra, Stéphane, Tissier, Frédérique, Coste, Joël, Abiven, Gwenaelle, Libé, Rossella, Bienvenu, Marie, Alberini, Jean-Louis, Salenave, Sylvie, Bouchard, Philippe, Bertherat, Jérôme, Dousset, Bertrand, Legmann, Paul, Richard, Bruno, Foehrenbach, Hervé, Bertagna, Xavier, Tenenbaum, Florence·2009·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2008-2302

Open this paper in CoChat — free account

Abstract

CONTEXT: Most adrenal incidentalomas are nonfunctioning adrenocortical adenomas (ACAs). Adrenocortical carcinomas (ACCs) are rare but should be recognized at an early stage. OBJECTIVE: The objective of the study was to evaluate the usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) to predict malignancy in patients without a previous history of cancer. DESIGN: This was a prospective, multicenter study from 2001 to 2006. SETTING: The study was conducted at a network of seven university hospitals in Paris. PATIENTS: Seventy-seven patients were included. All underwent surgery because of hypersecretory and/or growing benign lesions (n = 18), obvious ACCs (n = 21), or radiologically indeterminate lesions (n = 38). MAIN OUTCOME MEASURE: The degree of (18)F-FDG PET uptake [maximum standardized uptake value (maxSUV)] was related to the pathological findings serving as a reference, and its diagnostic value was compared with that of computerized tomography (CT) scan. RESULTS: Pathology eventually diagnosed 43 ACAs, 22 ACCs, and 12 nonadrenocortical lesions. Using a cutoff value above 1.45 for adrenal to liver maxSUV ratio, the sensitivity and specificity to distinguish ACAs from ACCs were, respectively, 1.00 (95% confidence interval 0.85-1.00) and 0.88 (95% confidence interval 0.75-0.96). Among the 38 indeterminate lesions at CT scan, we could analyze a subgroup of 16 adrenocortical tumors with high unenhanced density (>10 HU) and an inappropriate washout: (18)F-FDG PET correctly predicted the benignity in 13 of 15 ACAs. CONCLUSIONS: In a multidisciplinary team approach, (18)F-FDG PET helps to manage suspicious CT scan lesions. An adrenal to liver maxSUV ratio less than 1.45 is highly predictive of a benign lesion.

Integrity signals

Registry

Crossref · 10.1210/jc.2008-2302

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 3×
“The second CT scan parameter used to predict malignancy is the tumor size (2).”
BackgroundMethodInfluential
Incidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Clinical Applications of PET in Oncology
ROHREN, E. M., Turkington, T. G., & Coleman, R. E. (2004) · Radiology · doi:10.1148/radiol.2312021185 · Cited by 862
SUV: standard uptake or silly useless value?
Keyes, J. W. (1995) · PubMed · Cited by 803
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344099 · Cited by 712
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature
Boland, G. W., Lee, M. J., Gazelle, G. S., Halpern, E. F., McNicholas, M. M., & Mueller, P. R. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.1.9648789 · Cited by 693
Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT
Caoili, E. M., KOROBKIN, M. T., Francis, I. R., Cohan, R. H., Platt, J. F., Dunnick, N. R., & Raghupathi, K. I. (2002) · Radiology · doi:10.1148/radiol.2223010766 · Cited by 684
Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Self-citation
Anatomy of SUV
Huang, S. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00155-4 · Cited by 458
Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients
Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435
Self-citation
Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT
Peña, C. S., Boland, G. W. L., Hahn, P. F., Lee, M. J., & Mueller, P. R. (2000) · Radiology · doi:10.1148/radiology.217.3.r00dc29798 · Cited by 399
CT time-attenuation washout curves of adrenal adenomas and nonadenomas
Korobkin, M., Brodeur, F. J., Francis, I. R., Quint, L. E., Dunnick, N. R., & Londy, F. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.3.9490968 · Cited by 386
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun, M., Kim, W., Alnafisi, N., Lacorte, L., Jang, S., & Alavi, A. A. (2001) · PubMed · Cited by 336
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Erasmus, J. J., Patz, E. F., McAdams, H. P., Murray, J. G., Herndon, J. E., Coleman, R. E., & Goodman, P. C. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.5.9129444 · Cited by 330
Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT
Szolar, D. H., Korobkin, M., Reittner, P., Berghold, A., Bauernhofer, T., Trummer, H., Schoellnast, H., Preidler, K. W., & Samonigg, H. (2005) · Radiology · doi:10.1148/radiol.2342031876 · Cited by 314
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy- d -glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 303
18F-FDG PET/CT in the evaluation of adrenal masses.
Metser, U., Miller, E., Lerman, H., Lievshitz, G., Avital, S., & Even‐Sapir, E. (2006) · PubMed · Cited by 296
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Self-citation
The optimal imaging of adrenal tumours: a comparison of different methods
Ilias, Ι., Sahdev, A., Reznek, R. H., Grossman, A. B., & Pacák, K. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0045 · Cited by 266
Distinguishing Benign from Malignant Adrenal Masses: Multi–Detector Row CT Protocol with 10-Minute Delay
Blake, M. A., Kalra, M. K., Sweeney, A. T., Lucey, B. C., Maher, M. M., Sahani, D. V., Halpern, E. F., Müeller, P. R., Hahn, P. F., & Boland, G. W. (2006) · Radiology · doi:10.1148/radiol.2382041514 · Cited by 259
Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet, N., Albert, A., Foidart, J., & Hustinx, R. (2004) · PubMed · Cited by 257
Adrenal Cortical Carcinoma
Sullan, M., Boileau, M. A., & Hodges, C. V. (1978) · The Journal of Urology · doi:10.1016/s0022-5347(17)57317-6 · Cited by 255
Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Boland, G. W., Goldberg, M. A., Lee, M. J., Mayo-Smith, W. W., Dixon, J., McNicholas, M. M. J., & Müeller, P. R. (1995) · Radiology · doi:10.1148/radiology.194.1.7997539 · Cited by 222
18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.
Kumar, R., Xiu, Y., Yu, J. Q., Takalkar, A. M., El-Haddad, G. E., Potenta, S. E., Kung, J. W., Zhuang, H., & Alavi, A. A. (2004) · PubMed · Cited by 216
Advances in statistical methodology for the evaluation of diagnostic and laboratory tests
Campbell, G. D. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130513 · Cited by 214
Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy—Initial Experience
Blake, M. A., Slattery, J. M. A., Kalra, M. K., Halpern, E. F., Fischman, A. J., Müeller, P. R., & Boland, G. W. (2006) · Radiology · doi:10.1148/radiol.2383042164 · Cited by 185
Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed Tomography
Leboulleux, S., Dromain, C., Bonniaud, G., Auperin, A., Caillou, B., Lumbroso, J., Sigal, R., Baudin, É., & Schlumberger, M. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1540 · Cited by 169
FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection
Ramos, C. D., Erdi, Y. E., Gönen, M., Riedel, E., YEUNG, H. W. D., Macapinlac, H. A., Chisin, R., & Larson, S. M. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000421 · Cited by 139
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma
Mackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2612 · Cited by 115
FDG-PET and CT characterization of adrenal lesions in cancer patients
Jana, S., Zhang, T., Milstein, D., Isasi, C. R., & Blaufox, M. D. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1915-8 · Cited by 111
In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing’s Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism
Bertherat, J. Y., Contesse, V., Louiset, E., Barrande, G., Duparc, C., Groussin, L., Émy, P., BERTAGNA, X. Y., Kuhn, J., Vaudry, H., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1256 · Cited by 108
Self-citation
Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn, H. R. I., Salonen, A., Friberg, J., Roivainen, A., Viljanen, T., Långsjö, J., Salmi, J., Välimäki, M. J., Någren, K., & Nuutila, P. (2004) · PubMed · Cited by 105
FDG-PET in Adrenocortical Carcinoma
Becherer, A., Vierhapper, H., Pötzi, C., Karanikas, G., Kurtaran, A., Schmaljohann, J., Staudenherz, A., Dudczak, R., & Kletter, K. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801753131363 · Cited by 102
Differentiating Adrenal Adenomas From Nonadenomas Using 18F-FDG PET/CT
Caoili, E. M., KOROBKIN, M. T., Brown, R. K. J., Mackie, G. C., & Shulkin, B. L. (2007) · Academic Radiology · doi:10.1016/j.acra.2007.01.009 · Cited by 102
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
Tessonnier, L., Sebag, F. A., Palazzo, F. F., Colavolpe, C., Micco, C. D., Mancini, J., Conte‐Devolx, B., Henry, J. F., MUNDLER, O., & Taïeb, D. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0849-3 · Cited by 102
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Maurea, S., Klain, M., Mainolfi, C. G., Ziviello, M., & Salvatore, M. (2001) · PubMed · Cited by 101
Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri, B., Maurer, A. H., Cone, L., Doss, M., & Adler, L. P. (2004) · PubMed · Cited by 82
Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center
Luton, J., Martinez, M., Coste, J., & Bertherat, J. Y. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430111 · Cited by 70
Self-citation
A threshold method to improve standardized uptake value reproducibility
Lee, J. R., Madsen, M. T., Bushnell, D., & Menda, Y. (2000) · Nuclear Medicine Communications · doi:10.1097/00006231-200007000-00013 · Cited by 70
18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients
Tenenbaum, F., Groussin, L., Foehrenbach, H., Tissier, F., Gouya, H., Bertherat, J. Y., Dousset, B. E., Legmann, P., Richard, B., & BERTAGNA, X. Y. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500789 · Cited by 59
Self-citation
Imaging Techniques for Adrenal Lesion Characterization
Blake, M. A., Holalkere, N.-S., & Boland, G. W. (2008) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2008.01.003 · Cited by 55
Analysis of adrenal masses by 18F-FDG positron emission tomography scanning
Han, S. ‐., Kim, T., Jeon, S.-H., Jeong, S. J., Yun, M., Rhee, Y., Kang, E. S., Cha, B.-S., Lee, E. J., Lee, H.-C., et al. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01220.x · Cited by 49
F-18 Fluorodeoxyglucose Positron Emission Tomography-Positive Benign Adrenal Cortical Adenoma: Imaging Features and Pathologic Correlation
Rao, S. K., Caride, V. J., Ponn, R. B., Giakovis, E., & Lee, S. H. (2004) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000124008.68606.4c · Cited by 42
Sex steroids in androgen-secreting adrenocortical tumors: clinical and hormonal features in comparison with non-tumoral causes of androgen excess
d’Alva, C. B., Abiven, G., Viallon, V., Groussin, L., Dugué, M. A., BERTAGNA, X. Y., & Bertherat, J. Y. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0324 · Cited by 36
Self-citation
Adrenal Hyperplasia in Cushing’s Syndrome Demonstrated by FDG Positron Emission Tomographic Imaging
Lin, E. C., & HELGANS, R. (2002) · Clinical Nuclear Medicine · doi:10.1097/00003072-200207000-00010 · Cited by 19

Sorted by citations

Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Adrenocortical carcinoma
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523

See all 215

Authors: Groussin, L., Bonardel, G., Silvéra, S., Tissier, F., Coste, J., Abiven, G., Libé, R., Bienvenu, M., Alberini, J.-L., Salenave, S., Bouchard, P., Bertherat, J., Dousset, B., Legmann, P., Richard, B., Foehrenbach, H., Bertagna, X., & Tenenbaum, F.
Affiliations: Centre National de la Recherche Scientifique (FR)
HIA du Val-de-Grâce à Paris (FR)
Université Paris Descartes (L.G., S.Si., F.Ti., J.C., M.B., J.B., B.D., P.L., B.R., X.B.), 75006 Paris, France
Institut National de la Santé et de la Recherche Médicale Unité 567, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104, Institut Cochin, Department of Endocrinology, Metabolism and Cancer (L.G., F.Ti., R.L., J.B., X.B.), 75014 Paris, France
Hôpital Cochin (FR)
Université Paris Descartes (FR)
Université de Versailles Saint-Quentin-en-Yvelines (FR)
Assistance Publique – Hôpitaux de Paris (FR)
Nuclear Medicine (B.R., F.Te.), 75014 Paris, France
Corresponding author: Groussin, Lionel
ORCID: Groussin, Lionel
Bonardel, Gérald
Alberini, Jean-Louis
Bouchard, Philippe
Dousset, Bertrand
Richard, Bruno
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2009-05-01
Volume: 94
Issue: 5
Pages: 1713-1722
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2008-2302
OpenAlex: W2044368873
Cited by: 215
References: 53
Citations by year: 2026: 6 · 2025: 7 · 2024: 5 · 2023: 9 · 2022: 13 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 14 · 2017: 15 · 2016: 11 · 2015: 13 · 2014: 18 · 2013: 14 · 2012: 14
FWCI: 22.25
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
Keywords: 18F-FDG PET, adrenocortical tumors, adrenocortical carcinoma, adrenal adenoma, adrenal incidentaloma, malignancy prediction, standardized uptake value, preoperative diagnosis
MeSH terms: Adrenal Cortex Neoplasms, Adult, Aged, Blood Glucose, Female, Hormones, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Paris, Preoperative Care, Prospective Studies, Tomography, X-Ray Computed, Fluorodeoxyglucose F18, Diabetes Complications, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks